Level C· Early human research exploring benefitsProspective StudyEurope PMCOpen access

Stem/progenitor cells in closed suction drainage fluid after hip arthroplasty

Sera S., Ishikawa M., Adachi N., Yasunaga Y., Ochi M.

Prospective Study with a reported sample of 14 on Chronic Wound, Scar, published in Acta Orthop (2011) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Acta Orthop (2011)
Reported sample size
14
Source database
Europe PMC
PMID
21434846
PMCID
PMC3235294
DOI
10.3109/17453674.2011.566153

Abstract (original English)

Background and purpose Drainage after surgery is commonly used, and the contents are generally discarded as clinical waste. We analyzed closed suction drainage fluid from hip arthroplasty patients to determine whether any multipotent stem cells were present that could be used as a source of cells for tissue regeneration. Methods Drainage fluid was obtained from 14 patients after hip arthroplasty on the day of surgery, the next day, and 2 days after surgery. Peripheral blood and bone marrow from the iliac crest were also obtained from the same patients during surgery. These samples were examined using regular flow cytometric profiling, and we performed quantitative immunoassays of stromal-derived factor-1 (SDF1) levels in the plasma. Mononuclear cells (MNCs) from these samples were also isolated and cultured. Fibroblastic adherent cells from MNC fractions were cultured in an osteogenic and a chondrogenic differentiation medium and were then evaluated for multipotentency. Results and interpretation Fibroblastic adherent cells were isolated from the mononuclear cell fraction of bone marrow and drainage fluid on the day of surgery, but they were not present in either the mononuclear cell fraction of the peripheral blood or the drainage fluid on the next day and 2 days after surgery. The cells from the drainage fluid on the day of surgery could differentiate in vitro into osteogenic

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Multipotent Stem CellsHumansSurgical Wound InfectionPostoperative CareSuctionArthroplasty, Replacement, HipCell SeparationImmunophenotypingWound HealingCell Differentiation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research